Analytic Investors’s Gilead Sciences GILD Stock Holding History

Analytic Investors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$79.4M	Buy	1,003,604 +374,709	+60%	+$30.4M	0.89%	31
2016 Q2	$52.5M	Buy	628,895 +433,055	+221%	+$38.4M	0.62%	48
2016 Q1	$18M	Buy	195,840 +42,262	+28%	+$3.81M	0.22%	105
2015 Q4	$15.5M	Buy	153,578 +112,155	+271%	+$11.7M	0.19%	118
2015 Q3	$4.07M	Sell	41,423 -205,606	-83%	-$22.8M	0.05%	206
2015 Q2	$28.9M	Buy	247,029 +4,460	+2%	+$487K	0.41%	65
2015 Q1	$23.8M	Sell	242,569 -91,088	-27%	-$9.25M	0.33%	82
2014 Q4	$31.4M	Sell	333,657 -9,814	-3%	-$1.02M	0.45%	65
2014 Q3	$36.6M	Buy	343,471 +4,675	+1%	+$458K	0.52%	59
2014 Q2	$28.1M	Buy	338,796 +333,846	+6,744%	+$26M	0.45%	63
2014 Q1	$351K	Sell	4,950 -124,543	-96%	-$9.77M	0.01%	497
2013 Q4	$9.72M	Buy	129,493 +82,076	+173%	+$5.72M	0.16%	129
2013 Q3	$2.98M	Buy	47,417 +40,425	+578%	+$2.42M	0.05%	210
2013 Q2	$358K	Buy	+6,992	New	+$364K	0.01%	479

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Analytic Investors's GILD Position: Q3 2016 in Review

Analytic Investors increased its Gilead Sciences (GILD) stake by 60% in Q3 2016, buying an estimated $30.4M and bringing the position to 1,003,604 shares worth $79.4M. The position accounts for 0.89% of the portfolio, ranked #31.

Analytic Investors first reported a position in GILD in Q2 2013 and has held it in 14 quarters since. 1,557 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

Analytic Investors held 1,003,604 shares of Gilead Sciences worth $79.4M as of Q3 2016.
Analytic Investors bought 374,709 Gilead Sciences shares in Q3 2016, an estimated $30.4M.
Gilead Sciences made up 0.89% of Analytic Investors's portfolio in Q3 2016, its #31 holding.
Analytic Investors first reported a position in Gilead Sciences in Q2 2013 and has held it in 14 quarters since.
1,557 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.